A new trading day began on Tuesday, with Aptevo Therapeutics Inc (NASDAQ: APVO) stock price up 24.82% from the previous day of trading, before settling in for the closing price of $1.41. APVO’s price has ranged from $1.32 to $381.10 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 80.96%. Meanwhile, its annual earnings per share averaged 99.19%. With a float of $3.29 million, this company’s outstanding shares have now reached $3.29 million.
Aptevo Therapeutics Inc (APVO) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Aptevo Therapeutics Inc is 0.00%, while institutional ownership is 46.43%.
Aptevo Therapeutics Inc (APVO) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -355.2 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.9 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 99.19% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 83.99% during the next five years compared to 80.96% growth over the previous five years of trading.
Aptevo Therapeutics Inc (NASDAQ: APVO) Trading Performance Indicators
Here are Aptevo Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.27. For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -540.69, a number that is poised to hit -2.09 in the next quarter and is forecasted to reach -7.42 in one year’s time.
Technical Analysis of Aptevo Therapeutics Inc (APVO)
The latest stats from [Aptevo Therapeutics Inc, APVO] show that its last 5-days average volume of 12.77 million was superior to 2.54 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 27.03%.
During the past 100 days, Aptevo Therapeutics Inc’s (APVO) raw stochastic average was set at 3.38%, which indicates a significant decrease from 32.48% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1775 in the past 14 days, which was lower than the 0.4572 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.8522, while its 200-day Moving Average is $29.1595. Now, the first resistance to watch is $1.9500. This is followed by the second major resistance level at $2.1400. The third major resistance level sits at $2.3000. If the price goes on to break the first support level at $1.6000, it is likely to go to the next support level at $1.4400. The third support level lies at $1.2500 if the price breaches the second support level.
Aptevo Therapeutics Inc (NASDAQ: APVO) Key Stats
With a market capitalization of 5.79 million, the company has a total of 3,288K Shares Outstanding. Currently, annual sales are 0 K while annual income is -24,130 K. The company’s previous quarter sales were 0 K while its latest quarter income was -6,200 K.
